These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders. Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760 [TBL] [Abstract][Full Text] [Related]
3. SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway. Chim CS; Fung TK; Cheung WC; Liang R; Kwong YL Blood; 2004 Jun; 103(12):4630-5. PubMed ID: 14976049 [TBL] [Abstract][Full Text] [Related]
4. Methylated alteration of SHP1 complements mutation of JAK2 tyrosine kinase in patients with myeloproliferative neoplasm. Yang JJ; Chen H; Zheng XQ; Li HY; Wu JB; Tang LY; Gao SM Asian Pac J Cancer Prev; 2015; 16(6):2219-25. PubMed ID: 25824741 [TBL] [Abstract][Full Text] [Related]
5. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders. Fourouclas N; Li J; Gilby DC; Campbell PJ; Beer PA; Boyd EM; Goodeve AC; Bareford D; Harrison CN; Reilly JT; Green AR; Bench AJ Haematologica; 2008 Nov; 93(11):1635-44. PubMed ID: 18815196 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms. Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066 [TBL] [Abstract][Full Text] [Related]
7. [Study of hypermethylation of SOCS gene in typical myeloproliferative disease]. Qin W; Li LL; Lu HN; Huang BB; Xiu B; Bo LJ; Gao QM; Zhang WJ; Fu JF Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):772-6. PubMed ID: 22339915 [TBL] [Abstract][Full Text] [Related]
8. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. de Andrés MC; Imagawa K; Hashimoto K; Gonzalez A; Goldring MB; Roach HI; Oreffo RO Biochem Biophys Res Commun; 2011 Apr; 407(1):54-9. PubMed ID: 21352802 [TBL] [Abstract][Full Text] [Related]
9. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. Song MM; Shuai K J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039 [TBL] [Abstract][Full Text] [Related]
10. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296 [TBL] [Abstract][Full Text] [Related]
11. Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. Chen CQ; Yu K; Yan QX; Xing CY; Chen Y; Yan Z; Shi YF; Zhao KW; Gao SM Carcinogenesis; 2013 Jul; 34(7):1442-9. PubMed ID: 23430957 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Chim CS; Wong AS; Kwong YL Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685 [TBL] [Abstract][Full Text] [Related]
13. DNA methylation of SOCS1/2/3 predicts hepatocellular carcinoma recurrence after liver transplantation. Yang Z; Zhu H; Zhang L; Wei Q; Zhou L; Xu X; Song P; Liu J; Xie H; Zheng S Mol Biol Rep; 2020 Mar; 47(3):1773-1782. PubMed ID: 32006198 [TBL] [Abstract][Full Text] [Related]
14. Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms. Yasin EB; Alserihi R; Alkhatabi H; Qutob HMH; Qahwaji R; Kattan SW; Gholam KA; Hussein E; Barefah AS; Alghuthami ME; Abuzenadah A Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8451-8458. PubMed ID: 36459028 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal regulation of SOCS 1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. Zhou H; Miki R; Eeva M; Fike FM; Seligson D; Yang L; Yoshimura A; Teitell MA; Jamieson CA; Cacalano NA Clin Cancer Res; 2007 Apr; 13(8):2344-53. PubMed ID: 17438093 [TBL] [Abstract][Full Text] [Related]
16. SOCS2: inhibitor of JAK2V617F-mediated signal transduction. Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447 [TBL] [Abstract][Full Text] [Related]
17. [Study of single nucleotide polymorphism of SOCS gene in typical myeloproliferative neoplasms]. Qin W; Chen T; Yang JH; Zhang Y; Xiao R; Lu JT; Wang T; Zhou M; He JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1507-12. PubMed ID: 24370038 [TBL] [Abstract][Full Text] [Related]
18. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000 [TBL] [Abstract][Full Text] [Related]
19. [Research advances on relationship between suppressor of cytokine signaling 3 and myeloproliferative neoplasms]. Qin W; Fu JF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1101-4. PubMed ID: 20723338 [TBL] [Abstract][Full Text] [Related]
20. Regulation of STAT5 phosphorylation and interaction with SHP1 by lnc-AC004893, a long non-coding RNA overexpressed in myeloproliferative neoplasms. Yang J; Ruan J; Zhou B; Ye S; Gao S; Zheng X Hematology; 2024 Dec; 29(1):2375045. PubMed ID: 39012197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]